Most Recent Articles by Jennifer Britton-Colonnese, MSN, FNP-BC, CDE
Often, patients as consumers may not be aware that the products they are using for diabetes care are not protected by HIPAA.
The explosion of technological advances in the medical field poses challenges, including cybersecurity and potentially new malpractice claims.
A 25-year-old woman newly diagnosed with type 1 diabetes presents with insidious onset of recurrent hypoglycemia and is given a CGM device.
Endocrinology Advisor Articles
- Diabetic Retinopathy Screening Should Be Individualized Based on Eye Health, Glycated Hemoglobin
- USPSTF: No Thyroid Cancer Screening in Asymptomatic Adults
- The Handoff: Your Week in Endocrinology News - 5/19/17
- Fewer Menstrual Cycles May Lead to Increased Risk for Heart Failure
- Efficacy of Daily vs Weekly Levothyroxine for Hypothyroidism
- Liraglutide Plus Metformin Leads to Remission in New-Onset Type 2 Diabetes
- Comorbid Congestive Heart Failure Linked to Worse Outcomes When Receiving Parenteral Nutrition
- Early Insulin Therapy Improves Type 2 Diabetes Care
- Gestational Diabetes Risk May Be Reduced With Probiotics
- Testosterone Replacement Therapy May Protect Against Stroke, Heart Attack in Hypogonadism
- Frequent Hot Flashes Worsened Endothelial Function in Younger Midlife Women
- Increased Lifetime Risk of Depression In Children With Obesity
- Collaborative Care With Pharmacist Benefits Patients with Type 2 Diabetes
- CDC: Successful Start to National Diabetes Prevention Program
- Does Aerobic-Resistance Exercise Benefit Seniors With Obesity?